About Dr. James Kelly: Dr. James Kelly, MD is a renowned refractive surgeon specialist and comprehensive ophthalmologist in NYC and the tri state area.

Dec. 19, 2006 -- Thousands of feet up the frozen side of Oregon's Mount Hood, within a makeshift snow shelter so small it took rescue teams days to locate it, Kelly James spent the final hours of ...

Dr. James A. ‘Jim’ Block, the former president and chief executive officer of the Johns Hopkins Hospital and Health System, died Oct. 9 at his Ruxton residence. He was 83.

Dr. James Edmund Corry Jr. (Jim) has gone to be with his Lord and Savior Jesus Christ on April 27th, 2025 at the age of 75 in Lynn Haven, FL. He ...

Dr. James Edmund Corry Jr. (Jim) has gone to be with his Lord and Savior Jesus Christ on April 27th, 2025 at the age of 75 in Lynn Haven, FL. He was born on November 5th, 1949 in Quincy, Florida to ...

Dr. James “Jim” Finley Elliott, D. C. 79, passed away Friday, April 22, 2011, in Tulsa, OK. Born to Finley Harvey and Lydia Estelle (Warner) Elliott on January 26, 1932, ...

Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health ...

Dr. James Edmund Corry Jr. (Jim) has gone to be with his Lord and Savior Jesus Christ on April 27th, 2025 at the age of 75 in Lynn Haven, FL. He ...

Dr. James "Jim" Alan Schumacher, 88, of Zanesville passed at 7:25 P.M. Thursday, June 22, 2023 at the Primrose Retirement Community. He was born on Saturday, August 18, 1934 in Columbus, Ohio the ...

James Thomas Kelly, age 69, of Anderson, SC, passed away on Monday, November 18, 2024, at AnMed Medical Center with his loved ones by his side. ...

James (Jim) Luther Cole, born August 18, 1935, passed away May 8, 2024 at Longs Peak Hospital in Longmont Colorado. Viewing will be held Friday May 17, 2024 from 11am-1pm at Crist Mortuary at 3395 … ...

Dr. Kelly’s presentation, titled “The Use of a Novel Intranasal Neurosteroid to Treat Concussion Predicted to Have Poor Outcomes,” will focus on Oragenics' "Trigger-to-Treat" program for ...